Literature DB >> 34059101

Identification of anti-inflammatory compounds from Zhongjing formulae by knowledge mining and high-content screening in a zebrafish model of inflammatory bowel diseases.

Yunru Yu1, Jing Chen1, Xiaohui Zhang1, Yingchao Wang1, Shufang Wang1, Lu Zhao2, Yi Wang3,4,5.   

Abstract

BACKGROUND: Inflammatory bowel diseases (IBD) are chronic relapsing intestinal inflammations with increasing global incidence, and new drug development remains in urgent demand for IBD management. To identify effective traditional Chinese medicine (TCM) formulae and compounds in IBD treatment, we innovatively combined the techniques of knowledge mining, high-content screening and high-resolution mass spectrometry, to conduct a systematic screening in Zhongjing formulae, which is a large collection of TCM prescriptions with most abundant clinical evidences.
METHODS: Using Word2vec-based text learning, the correlations between 248 Zhongjing formulae and IBD typical symptoms were analyzed. Next, from the top three formulae with predicted relationship with IBD, TCM fractions were prepared and screened on a transgenic zebrafish IBD model for their therapeutic effects. Subsequently, the chemical compositions of the fraction hits were analyzed by mass spectrometry, and the major compounds were further studied for their anti-IBD effects and potential mechanisms.
RESULTS: Through knowledge mining, Peach Blossom Decoction, Pulsatilla Decoction, and Gegen Qinlian Decoction were predicted to be the three Zhongjing formulae mostly related to symptoms typical of IBD. Seventy-four fractions were prepared from the three formulae and screened in TNBS-induced zebrafish IBD model by high-content analysis, with the inhibition on the intestinal neutrophil accumulation and ROS level quantified as the screening criteria. Six herbal fractions showed significant effects on both pathological processes, which were subsequently analyzed by mass spectrometry to determine their chemical composition. Based on the major compounds identified by mass spectrometry, a second-round screen was conducted and six compounds (palmatine, daidzin, oroxyloside, chlorogenic acid, baicalin, aesculin) showed strong inhibitory effects on the intestinal inflammation phenotypes. The expression of multiple inflammatory factors, including il1β, clcx8a, mmp and tnfα, were increased in TNBS-treated fish, which were variously inhibited by the compounds, with aesculin showing the most potent effects. Moreover, aesculin and daidzin also upregulated e-cadherin's expression.
CONCLUSION: Taken together, we demonstrated the regulatory effects of several TCM formulae and their active compounds in the treatment of IBD, through a highly efficient research strategy, which can be applied in the discovery of effective TCM formulae and components in other diseases.

Entities:  

Keywords:  High-content screening; Inflammatory bowel diseases; Knowledge mining; Multimodal identification; Zebrafish; Zhongjing formulae

Year:  2021        PMID: 34059101     DOI: 10.1186/s13020-021-00452-z

Source DB:  PubMed          Journal:  Chin Med        ISSN: 1749-8546            Impact factor:   5.455


  65 in total

Review 1.  Considerations of traditional Chinese medicine as adjunct therapy in the management of ulcerative colitis.

Authors:  Chi Zhang; Miao Jiang; Aiping Lu
Journal:  Clin Rev Allergy Immunol       Date:  2013-06       Impact factor: 8.667

2.  The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine.

Authors:  Youyou Tu
Journal:  Nat Med       Date:  2011-10-11       Impact factor: 53.440

Review 3.  Cytokines in inflammatory bowel disease.

Authors:  Markus F Neurath
Journal:  Nat Rev Immunol       Date:  2014-04-22       Impact factor: 53.106

Review 4.  Therapeutic Opportunities in Inflammatory Bowel Disease: Mechanistic Dissection of Host-Microbiome Relationships.

Authors:  Damian R Plichta; Daniel B Graham; Sathish Subramanian; Ramnik J Xavier
Journal:  Cell       Date:  2019-08-22       Impact factor: 41.582

5.  Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice.

Authors:  Ken Sugimoto; Hiroyuki Hanai; Kotaro Tozawa; Taiki Aoshi; Masato Uchijima; Toshi Nagata; Yukio Koide
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

6.  In vivo analysis of gut function and disease changes in a zebrafish larvae model of inflammatory bowel disease: a feasibility study.

Authors:  Angeleen Fleming; Janusz Jankowski; Paul Goldsmith
Journal:  Inflamm Bowel Dis       Date:  2010-07       Impact factor: 5.325

Review 7.  Mouse models of inflammatory bowel disease.

Authors:  Stefan Wirtz; Markus F Neurath
Journal:  Adv Drug Deliv Rev       Date:  2007-08-16       Impact factor: 15.470

8.  Chemically induced intestinal damage models in zebrafish larvae.

Authors:  Stefan H Oehlers; Maria Vega Flores; Christopher J Hall; Kazuhide S Okuda; John Oliver Sison; Kathryn E Crosier; Philip S Crosier
Journal:  Zebrafish       Date:  2013-02-28       Impact factor: 1.985

Review 9.  Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease.

Authors:  Guang Xi Zhou; Zhan Ju Liu
Journal:  J Dig Dis       Date:  2017-09       Impact factor: 2.325

Review 10.  Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease.

Authors:  Bao-Jian Guo; Zhao-Xiang Bian; Hong-Cong Qiu; Yi-Tao Wang; Ying Wang
Journal:  Ann N Y Acad Sci       Date:  2017-08       Impact factor: 5.691

View more
  2 in total

1.  Multimodal Identification by Transcriptomics and Multiscale Bioassays of Active Components in Xuanfeibaidu Formula to Suppress Macrophage-Mediated Immune Response.

Authors:  Lu Zhao; Hao Liu; Yingchao Wang; Shufang Wang; Dejin Xun; Yi Wang; Yiyu Cheng; Boli Zhang
Journal:  Engineering (Beijing)       Date:  2021-11-15       Impact factor: 7.553

2.  Network pharmacology and molecular docking reveal zedoary turmeric-trisomes in Inflammatory bowel disease with intestinal fibrosis.

Authors:  Lie Zheng; Yong-Yi Ji; Yan-Cheng Dai; Xin-Li Wen; Shi-Cheng Wu
Journal:  World J Clin Cases       Date:  2022-08-06       Impact factor: 1.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.